{"disease":{"id":"fetal-and-neonatal-alloimmune-thrombocytopenia","name":"fetal and neonatal alloimmune thrombocytopenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05345561","title":"Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia","phase":"","overall_status":"COMPLETED","enrollment_count":14390,"lead_sponsor_name":"Rallybio","has_results":false},{"nct_id":"NCT04067375","title":"Towards Routine HPA-screening In Pregnancy to Prevent FNAIT","phase":"","overall_status":"COMPLETED","enrollment_count":3660,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT04529382","title":"Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia","phase":"","overall_status":"UNKNOWN","enrollment_count":78,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT03561909","title":"Kinetics of Blood Platelets Transfused to Healthy Subjects","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Prophylix Pharma AS","has_results":false},{"nct_id":"NCT06435845","title":"Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Rallybio","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}